"Kaijie" Anminning Membrane Rupture (Placental Microglobulin) Assay (Sterilized) - Taiwan Registration f9ddfede5c3807133486c09a262e0532
Access comprehensive regulatory information for "Kaijie" Anminning Membrane Rupture (Placental Microglobulin) Assay (Sterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number f9ddfede5c3807133486c09a262e0532 and manufactured by QIAGEN. The authorized representative in Taiwan is QIAGEN TAIWAN COMPANY LIMITED.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
It is limited to the first level of identification scope of the "Uric pH (Non-quantitative) Test System (A.1550)" of the Measures for the Classification and Grading of Medical Devices.
A Clinical chemistry and clinical toxicology
A.1550 Uric pH (non-quantitative) testing system
QMS/QSD;; ่ผธๅ ฅ
Dates and Status
Jul 31, 2017
Jul 31, 2027